Scholars Central

Research articlePublished 23 Sep 2008

The Risk management in the development of new products in the pharmaceutical industry.

Authors: Ewa Kleczyk

Global Journal of Business Management

Volume 3 · Issue 1 · Pages 1–9

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

One of the greatest challenges facing the pharmaceutical industry is the process of selecting which new products to develop. In this study, the product development and investment decision problem was examined. A hypothetical case of new product investment in either Product A and/or Product B by a hypothetical company called Healthcare Company was investigated. As employed in previous empirical studies, the NPV framework was utilized to examine the strategies for new product development. Additionally, the stochastic dominance methodology was employed to help with further examination of the dominant strategy. Three investment scenarios were investigated in this article: 100% of investment devoted to only one of the products and an equal investment in each of the drugs. The results suggested that the healthcare company should only invest in one of the pharmaceutical drugs. All of the methods utilized in this study yielded consistent outcomes.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalGlobal Journal of Business Management
  • SubjectBusiness & Management
  • BylineArticles whose byline prints “Ewa Kleczyk”